Clinical Trials on Human Immunodeficiency Virus Infection in Denmark

Total 233 results

Janssen-Cilag International NV

Completed

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment (PROTEA)

Human Immunodeficiency Virus (HIV) Infections | Acquired Immunodeficiency Syndrome (AIDS) Virus

France, United Kingdom, Belgium, Germany, Spain, Switzerland, Denmark, Israel, Austria, Poland, Hungary, Sweden, Ireland
GlaxoSmithKline

Completed

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects (ASSERT)

HIV Infection | Infection, Human Immunodeficiency Virus I

Germany, Belgium, United Kingdom, Spain, Ireland, Italy, France, Austria, Denmark, Netherlands, Switzerland, Portugal, Latvia
ViiV Healthcare

Terminated

GW873140 In Combination With Kaletra In HIV Infected Subjects

HIV Infection | Infection, Human Immunodeficiency Virus I

United States, Germany, France, Canada, Spain, Italy, Portugal, United Kingdom, Denmark, Netherlands
Danish Cancer Society
Merck Sharp & Dohme LLC

Completed

Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men

Human Papillomavirus Infection

Denmark
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Infection, Human Immunodeficiency Virus I

United States, Spain, Germany, Australia, Canada, Belgium, Denmark, Netherlands, United Kingdom, France, Italy, Romania
Pronova BioPharma
Aalborg University Hospital

Completed

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Ischemic Heart Disease | Human Immunodeficiency Virus

Denmark
Rockefeller University
Aarhus University Hospital; University Hospital of Cologne

Completed

Romidepsin Plus 3BNC117 Phase 2a Study (ROADMAP)

Human Immunodeficiency Virus (HIV)

Germany, Denmark, United States
Janssen-Cilag International NV

Completed

Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir (MONET)

HIV Infections | Human Immunodeficiency Virus | Acquired Immunodeficiency Syndrome Virus | AIDS Virus

United Kingdom, Belgium, Germany, Spain, Portugal, Israel, Denmark, Russian Federation, Austria, Hungary, Switzerland
Tibotec Pharmaceuticals, Ireland

Completed

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

HIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1

United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
Aalborg University Hospital

Unknown

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 (HEPVACHIV)

HIV Infections | Hepatitis B | Hepatitis A

Denmark
Rigshospitalet, Denmark

Recruiting

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

COVID-19 | Influenza | RSV Infection

Denmark
Gitte Kronborg
Rigshospitalet, Denmark; Hvidovre University Hospital; Statens Serum Institut; Ministry...

Completed

Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection (HIV-VAC)

HIV INFECTIONS

Denmark
Statens Serum Institut
Rigshospitalet, Denmark; Hvidovre University Hospital

Completed

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection (HIVDCVac)

HIV Infections

Denmark
Presidio Pharmaceuticals, Inc.

Completed

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Chronic Genotype 1 Hepatitis C Virus Infection

United Kingdom, Denmark, United States
Santaris Pharma A/S

Completed

Safety Study of SPC3649 in Healthy Men

Hepatitis C

Denmark
Tor Biering-Sørensen
Sanofi Pasteur, a Sanofi Company

Completed

Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting (DANFLU-1)

Influenza

Denmark
University of Aarhus
Aarhus University Hospital; Monash Medical Centre

Unknown

Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders

Hepatitis B

Denmark
Ulla Bonde van Zwol
University of Southern Denmark; Region of Southern Denmark; MCM Vaccines B.V.

Unknown

Human Papillomavirus and Pregnancy (HPVandPregn)

HPV-infection in Pregnant Women

Denmark
Tor Biering-Sørensen
Sanofi; Statens Serum Institut

Recruiting

A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults (DANFLU-2)

Influenza

Denmark
Copenhagen Studies on Asthma in Childhood
Novartis

Completed

H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women

H1N1v Influenza

Denmark
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

Hepatitis B

Denmark, Belgium
Tor Biering-Sørensen
Sanofi Pasteur, a Sanofi Company; Statens Serum Institut

Completed

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake (NUDGE-FLU)

Influenza | Behavior and Behavior Mechanisms

Denmark
University Hospital, Gentofte, Copenhagen

Recruiting

InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection (FluHeart)

Influenza | Cardiovascular Complication

Denmark
Tor Biering-Sørensen
Statens Serum Institut

Active, not recruiting

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults (NUDGE-FLU-2)

Influenza | Behavior and Behavior Mechanisms

Denmark
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Rikshospitalet University...

Recruiting

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients (EVITA)

Post-transplant Lymphoproliferative Disorder | EBV Infection | EBV Viremia | Epstein-Barr Virus Associated Lymphoproliferative Disorder

Denmark, Norway
Chronic Obstructive Pulmonary Disease Trial Network...
The Novo Nordic Foundation

Not yet recruiting

Vaccine Pandemic Preparedness Through Airway Immunology Characterization (VAXXAIR)

Influenza, Human

United Kingdom, Denmark
Rigshospitalet, Denmark
Statens Serum Institut

Completed

Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Neonatal Infection | Viral Infection | Neonatal Sepsis | Neonatal Death | Herpes Simplex Virus Infection | Newborn; Infection | Neonatal Herpes Simplex Infection | Neonatal HSV Infection

Denmark
Rigshospitalet, Denmark

Completed

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Autoimmune Hepatitis

Denmark
Janssen-Cilag International NV

Completed

A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients (SENSE)

Acquired Immunodeficiency Syndrome | HIV Infection | HIV

France, United Kingdom, Germany, Spain, Switzerland, Israel, Russian Federation, Austria, Hungary, Romania, Denmark
Chronic Obstructive Pulmonary Disease Trial Network...

Terminated

Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 (ProPAC-COVID)

Virus Diseases | Corona Virus Infection | Infection Viral

Denmark
GlaxoSmithKline

Completed

Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults

Hepatitis B

Austria, Belgium, Denmark, Iceland
Tor Biering-Sørensen
Statens Serum Institut

Active, not recruiting

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease

Influenza | Behavior and Behavior Mechanisms

Denmark
Rigshospitalet, Denmark
Copenhagen University Hospital, Hvidovre

Completed

Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic Steatosis (FitLiver)

Hepatitis B, Chronic | Hepatic Steatosis

Denmark
Susanne Dam Nielsen, MD, DMSc
Odense University Hospital; Aarhus University Hospital; Technical University...

Recruiting

Herpes Virus Infections in Kidney Transplant Patients (HINT)

Varicella Zoster Virus Infection | Vaccine-Preventable Diseases | Kidney Transplant; Complications

Denmark
Susanne Dam Nielsen, MD, DMSc
Rigshospitalet, Denmark; Technical University of Denmark

Recruiting

Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study (HISTORY)

Varicella Zoster Virus Infection | Cytomegalovirus Infections | Liver Transplant; Complications

Denmark
Rigshospitalet, Denmark

Recruiting

Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?

Corona Virus Infection | SARS-CoV Infection | Coronavirus

Denmark
Henning Bliddal

Completed

C-reactive Protein Levels Among Individuals With COVID-19

Coronavirus Infection

Denmark
GlaxoSmithKline

Completed

Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over

Influenza

Norway, Estonia, Denmark
University of Aarhus
Aarhus University Hospital

Completed

Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C

Hepatitis C

Denmark
Foundation for Innovative New Diagnostics, Switzerland

Completed

Truenat™ HCV RNA Assay Evaluation

Hepatitis C

Denmark, Ethiopia, Georgia, Thailand, Ukraine
Inger Lise Gade
Aarhus University Hospital Skejby

Completed

Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate (VTE-COVID-19)

Covid19 | Corona Virus Infection

Denmark
Thomas Benfield

Completed

Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals (AVERTAS)

Cardiovascular Diseases | HIV Infections | Hiv | Weight Change, Body | HIV Lipodystrophy | HIV Cardiomyopathy

Denmark
University of Aarhus
AbbVie; Aarhus University Hospital

Completed

Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C

Hepatitis C

Denmark
Northern Orthopaedic Division, Denmark

Completed

Cultures a.m.Kamme-Lindbergh in Suspicion of Infected TKA

Total Knee Arthritis | Viral; Infection, Slow Virus

Denmark
University of Aarhus
Massachusetts General Hospital; Novartis; Aarhus University Hospital; Monash University and other collaborators

Completed

Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART (CLEAR)

HIV Infection

Denmark
University of Aarhus

Completed

The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.

Alcoholic Hepatitis

Denmark
University of Aarhus

Completed

Protective Immune Mechanisms in Alcoholic Hepatitis (AHIL)

Alcoholic Hepatitis

Denmark
University of Aarhus

Completed

Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis

Alcoholic Hepatitis

Denmark
Rigshospitalet, Denmark

Completed

Ablation of Hepatocellular Carcinoma: a Nationwide Study

Hepatocellular Carcinoma | Hepatitis C | Ablation

Denmark
Region Zealand

Completed

Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic

Gastroenteritis | Infectious Disease | Dehydration in Children | COVID-19 Pandemic | Norovirus Infections | Rota Virus Gastroenteritis

Denmark

Clinical Trials on Human Immunodeficiency Virus Infection in Denmark

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations